Clinigen CFO Martin Abell to stand down

Pharmaceutical and services company Clinigen Group said its chief financial officer Martin Abell had resigned and would leave the business at the end of March.

He would replaced by Nick Keher, most previously head of Royal Bank of Canada's European healthcare equity research team.

Keher would take up the role from 19 March.

At 2:15pm: (LON:CLIN) Clinigen Group share price was -8.5p at 802.5p